2-Year Follow-up and High-Risk Subset Analysis of Zuma-1, the Pivotal Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Refractory Large B Cell Lymphoma
Resource Type
Abstract
Authors
Neelapu, Sattva S. ; Ghobadi, Armin ; Jacobson, Caron A. ; Miklos, David B. ; Lekakis, Lazaros J. ; Oluwole, Olalekan O. ; Lin, Yi ; Braunschweig, Ira ; Hill, Brian T. ; Timmerman, John M. ; Deol, Abhinav ; Reagan, Patrick M. ; Stiff, Patrick J. ; Flinn, Ian W. ; Farooq, Umar ; Goy, Andre ; McSweeney, Peter A. ; Munoz, Javier ; Siddiqi, Tanya ; Chavez, Julio C. ; Herrera, Alex F. ; Xue, Allen ; Jiang, Yizhou ; Bot, Adrian ; Rossi, John M. ; Kim, Jenny J. ; Go, William Y. ; Locke, Frederick L.
Source
In Blood 29 November 2018 132 Supplement 1:2967-2967
Subject
Language
ISSN
0006-4971